🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
An immunomodulatory protocol, experimentally-proven to promote T-regulatory...
Status
Unknown
Location
UZ Leuven
Start Date
2000-10
Trial ID
NCT02314949
Treatments Being Tested
The primary purpose of this Phase 1 study is to evaluate the safety, tolera...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-08-27
Trial ID
NCT02428309
Treatments Being Tested
This is a phase I single center dose escalation study with an extension at ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-11-08
Trial ID
NCT01634217
Treatments Being Tested
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested
This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-11
Trial ID
NCT06821503
The goal of this pilot intervention trial is to investigate the biological ...
Status
Completed
Location
Optic Neuritis Clinic, Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital, Rigshospitalet-Glostrup
Start Date
2024-11-14
Trial ID
NCT06674018
Treatments Being Tested
Measure the frequency of Follicular helper Tcells and Follicular regulatory...
Status
Unknown
Location
Multiple Locations
Start Date
2025-05
Trial ID
NCT06521359
Treatments Being Tested
This study will evaluate the ability of lung transplant recipients to react...
Status
Completed
Location
Duke University Medical Center
Start Date
2005-06-23
Trial ID
NCT00340951
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested